The Th2 systemic immune milieu enhances cutaneous inflammation in the K14-IL-4-transgenic atopic dermatitis model

Journal of Investigative Dermatology

Volumn 131, Issue 3, 2011, Pages 791-794

  Reichle, Marie E ^a   Chen, Lin ^b   Lin, Shao Xia ^a   Chan, Lawrence S ^a,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ATOPIC DERMATITIS; IMMUNE RESPONSE; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LETTER; NONHUMAN; PRIORITY JOURNAL; SKIN INFLAMMATION; TH2 CELL; TRANSGENIC ANIMAL;

EID: 79951514903     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.382     Document Type: Letter

References (15)

1. Bonness S, Bieber T (2007) Molecular basis of atopic dermatitis. Curr Opin Allergy Clin Immunol 7:382-6 (Pubitemid 47415280)
2. Chan LS, Robinson N, Xu L (2001) Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 117:977-83 (Pubitemid 33001220)
3. Chen L, Lin S-X, Amin S et al. (2010) VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model. Immunol Cell Biol 88:334-42
4. Chen L, Lin SX, Overbergh L et al. (2005b) The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the up-regulation of B cell activation molecules, proliferation and surface and serum IgE. Clin Exp Immunol 142:21-30 (Pubitemid 41361001)
5. Chen L, Marble DJ, Agha R et al. (2008a) The progression of inflammation parallels the dermal angiogenesis in a keratin 14 IL-4-transgenic model of atopic dermatitis. Micro-circulation 15:49-64
6. Chen L, Martinez O, Overbergh L et al. (2004) Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol 138:375-83
7. Chen L, Martinez O, Venkataramani P et al. (2005a) Correlation of disease evolution with progressive inflammatory cell activation and migration in the IL-4 transgenic mouse model of atopic dermatitis. Clin Exp Immunol 139:189-201 (Pubitemid 40222836)
8. Chen L, Overbergh L, Mathieu C et al. (2008b) The development of atopic dermatitis is independent of immunoglobulin E up-regula-tion in the k14-IL-4 SKH1 mouse model. Clin Exp Allergy 38:1367-80 (Pubitemid 352019657)
9. Hanifin JM (2009) Evolving concepts of pathogen-esis of atopic dermatitis and other eczemas. J Invest Dermatol 129:320-2
10. Jones HE, Inouye JC, McGerity JL et al. (1975) Atopic disease and serum immunoglobulin-E. Br J Dermatol 92:17-25
11. Lee GR, Flavell RA (2004) Transgenic mice which overproduce Th2 cytokines develop spontaneous atopic dermatitis and asthma. Int Immunol 16:1155-60 (Pubitemid 39136732)
12. Lopez-Kostka S, Dinges S, Griewank K et al. (2009) IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J Immunol 182:3039-46
13. Novak N, Bieber T (2003) Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 112:252-62 (Pubitemid 36981361)
14. Sigurdsson V, De Vries IJ, Toonstra J et al. (2000) Expression of VCAM-1, ICAM-1, E-selectin, and P-selectin on endothelium in situ in patients with erythroderma, mycosis fungoides and atopic dermatitis. J Cutan Pathol 27:436-40
15. Yamamura M, Uyemura K, Keans RJ et al. (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277-9 (Pubitemid 21917340)